АНАЛИЗ ЭФФЕКТИВНОСТИ ЛЕЧЕНИЯ И ПРОДОЛЖИТЕЛЬНОСТИ ЖИЗНИ КОШЕК С РАКОМ МОЛОЧНОЙ ЖЕЛЕЗЫ ПОСЛЕ ПРОВЕДЕНИЯ НЕАДЪЮВАНТНОЙ МОНОХИМИОТЕРАПИИ ГЕМЦИТАБИНОМ

Summary Breast cancer (BC) - a progressive and often inoperable disease, is the most common cancer in cats. He has a high degree of malignancy and poor prognosis. Gemcitabine chemotherapy as an intravenous infusion of 800 mg/m 2 input three-course is one of the main treatments for metastatic breast cancer, achieving stabilization of the tumor, moderate life.